1h Free Analyst Time
The antidepressants drugs market is forecasted to grow by USD 4.58 billion during 2024-2029, accelerating at a CAGR of 4.6% during the forecast period. The report on the antidepressants drugs market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.Speak directly to the analyst to clarify any post sales queries you may have.
The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by rising prevalence of depression, alliances and collaborations, and awareness programs for depression.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market size data, segment with regional analysis and vendor landscape in addition to an analysis of the key companies. Reports have historic and forecast data.
The antidepressants drugs market is segmented as below:
By Disease Type
- Major depressive disorder
- Obsessive compulsive disorder
- Others
By Distribution Channel
- Retail pharmacies
- Hospital pharmacies
- Online pharmacies
By Route Of Administration
- Oral
- Intravenous (IV)
- Nasal
- Subcutaneous
- Others
By Geographical Landscape
- North America
- Europe
- Asia
- Rest of World (ROW)
The report on the antidepressants drugs market covers the following areas:
- Antidepressants Drugs Market sizing
- Antidepressants Drugs Market forecast
- Antidepressants Drugs Market industry analysis
The report presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive primary and secondary research. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast accurate market growth.
Table of Contents
1 Executive Summary
1.1 Market overview
- Executive Summary - Chart on Market Overview
- Executive Summary - Data Table on Market Overview
- Executive Summary - Chart on Global Market Characteristics
- Executive Summary - Chart on Market By Geographical Landscape
- Executive Summary - Chart on Market Segmentation by Disease Type
- Executive Summary - Chart on Market Segmentation by Distribution Channel
- Executive Summary - Chart on Market Segmentation by Route of Administration
- Executive Summary - Chart on Incremental Growth
- Executive Summary - Data Table on Incremental Growth
- Executive Summary - Chart on Company Market Positioning
2 Market Analysis
2.1 Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
- Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
- Overview on criticality of inputs and factors of differentiation
- Overview on factors of disruption
- Impact of drivers and challenges in 2024 and 2029
3 Market Landscape
3.1 Market ecosystem
- Parent Market
- Data Table on - Parent Market
- Market characteristics analysis
- Value chain analysis
4 Market Sizing
4.1 Market definition
4.4 Market outlook: Forecast for 2024-2029
- Offerings of companies included in the market definition
- Market segments
4.4 Market outlook: Forecast for 2024-2029
- Chart on Global - Market size and forecast 2024-2029 ($ million)
- Data Table on Global - Market size and forecast 2024-2029 ($ million)
- Chart on Global Market: Year-over-year growth 2024-2029 (%)
- Data Table on Global Market: Year-over-year growth 2024-2029 (%)
5 Historic Market Size
5.1 Global Antidepressants Drugs Market 2019 - 2023
- Historic Market Size - Data Table on Global Antidepressants Drugs Market 2019 - 2023 ($ million)
- Historic Market Size - Disease Type Segment 2019 - 2023 ($ million)
- Historic Market Size - Distribution Channel Segment 2019 - 2023 ($ million)
- Historic Market Size - Route of Administration Segment 2019 - 2023 ($ million)
- Historic Market Size - Geography Segment 2019 - 2023 ($ million)
- Historic Market Size - Country Segment 2019 - 2023 ($ million)
6 Qualitative Analysis
6.1 The AI impact on Global Antidepressants Drugs Market
7 Five Forces Analysis
7.1 Five forces summary
- Five forces analysis - Comparison between 2024 and 2029
- Bargaining power of buyers - Impact of key factors 2024 and 2029
- Bargaining power of suppliers - Impact of key factors in 2024 and 2029
- Threat of new entrants - Impact of key factors in 2024 and 2029
- Threat of substitutes - Impact of key factors in 2024 and 2029
- Threat of rivalry - Impact of key factors in 2024 and 2029
- Chart on Market condition - Five forces 2024 and 2029
8 Market Segmentation by Disease Type
8.1 Market segments
- Chart on Disease Type - Market share 2024-2029 (%)
- Data Table on Disease Type - Market share 2024-2029 (%)
- Chart on Comparison by Disease Type
- Data Table on Comparison by Disease Type
- Chart on Major depressive disorder - Market size and forecast 2024-2029 ($ million)
- Data Table on Major depressive disorder - Market size and forecast 2024-2029 ($ million)
- Chart on Major depressive disorder - Year-over-year growth 2024-2029 (%)
- Data Table on Major depressive disorder - Year-over-year growth 2024-2029 (%)
- Chart on Obsessive compulsive disorder - Market size and forecast 2024-2029 ($ million)
- Data Table on Obsessive compulsive disorder - Market size and forecast 2024-2029 ($ million)
- Chart on Obsessive compulsive disorder - Year-over-year growth 2024-2029 (%)
- Data Table on Obsessive compulsive disorder - Year-over-year growth 2024-2029 (%)
- Chart on Others - Market size and forecast 2024-2029 ($ million)
- Data Table on Others - Market size and forecast 2024-2029 ($ million)
- Chart on Others - Year-over-year growth 2024-2029 (%)
- Data Table on Others - Year-over-year growth 2024-2029 (%)
- Market opportunity by Disease Type ($ million)
- Data Table on Market opportunity by Disease Type ($ million)
9 Market Segmentation by Distribution Channel
9.1 Market segments
- Chart on Distribution Channel - Market share 2024-2029 (%)
- Data Table on Distribution Channel - Market share 2024-2029 (%)
- Chart on Comparison by Distribution Channel
- Data Table on Comparison by Distribution Channel
- Chart on Retail pharmacies - Market size and forecast 2024-2029 ($ million)
- Data Table on Retail pharmacies - Market size and forecast 2024-2029 ($ million)
- Chart on Retail pharmacies - Year-over-year growth 2024-2029 (%)
- Data Table on Retail pharmacies - Year-over-year growth 2024-2029 (%)
- Chart on Hospital pharmacies - Market size and forecast 2024-2029 ($ million)
- Data Table on Hospital pharmacies - Market size and forecast 2024-2029 ($ million)
- Chart on Hospital pharmacies - Year-over-year growth 2024-2029 (%)
- Data Table on Hospital pharmacies - Year-over-year growth 2024-2029 (%)
- Chart on Online pharmacies - Market size and forecast 2024-2029 ($ million)
- Data Table on Online pharmacies - Market size and forecast 2024-2029 ($ million)
- Chart on Online pharmacies - Year-over-year growth 2024-2029 (%)
- Data Table on Online pharmacies - Year-over-year growth 2024-2029 (%)
- Market opportunity by Distribution Channel ($ million)
- Data Table on Market opportunity by Distribution Channel ($ million)
10 Market Segmentation by Route of Administration
10.1 Market segments
- Chart on Route of Administration - Market share 2024-2029 (%)
- Data Table on Route of Administration - Market share 2024-2029 (%)
- Chart on Comparison by Route of Administration
- Data Table on Comparison by Route of Administration
- Chart on Oral - Market size and forecast 2024-2029 ($ million)
- Data Table on Oral - Market size and forecast 2024-2029 ($ million)
- Chart on Oral - Year-over-year growth 2024-2029 (%)
- Data Table on Oral - Year-over-year growth 2024-2029 (%)
- Chart on Intravenous (IV) - Market size and forecast 2024-2029 ($ million)
- Data Table on Intravenous (IV) - Market size and forecast 2024-2029 ($ million)
- Chart on Intravenous (IV) - Year-over-year growth 2024-2029 (%)
- Data Table on Intravenous (IV) - Year-over-year growth 2024-2029 (%)
- Chart on Nasal - Market size and forecast 2024-2029 ($ million)
- Data Table on Nasal - Market size and forecast 2024-2029 ($ million)
- Chart on Nasal - Year-over-year growth 2024-2029 (%)
- Data Table on Nasal - Year-over-year growth 2024-2029 (%)
- Chart on Subcutaneous - Market size and forecast 2024-2029 ($ million)
- Data Table on Subcutaneous - Market size and forecast 2024-2029 ($ million)
- Chart on Subcutaneous - Year-over-year growth 2024-2029 (%)
- Data Table on Subcutaneous - Year-over-year growth 2024-2029 (%)
- Chart on Others - Market size and forecast 2024-2029 ($ million)
- Data Table on Others - Market size and forecast 2024-2029 ($ million)
- Chart on Others - Year-over-year growth 2024-2029 (%)
- Data Table on Others - Year-over-year growth 2024-2029 (%)
- Market opportunity by Route of Administration ($ million)
- Data Table on Market opportunity by Route of Administration ($ million)
11 Customer Landscape
11.1 Customer landscape overview
- Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
12 Geographic Landscape
12.1 Geographic segmentation
- Chart on Market share By Geographical Landscape 2024-2029 (%)
- Data Table on Market share By Geographical Landscape 2024-2029 (%)
- Chart on Geographic comparison
- Data Table on Geographic comparison
- Chart on North America - Market size and forecast 2024-2029 ($ million)
- Data Table on North America - Market size and forecast 2024-2029 ($ million)
- Chart on North America - Year-over-year growth 2024-2029 (%)
- Data Table on North America - Year-over-year growth 2024-2029 (%)
- Chart on Europe - Market size and forecast 2024-2029 ($ million)
- Data Table on Europe - Market size and forecast 2024-2029 ($ million)
- Chart on Europe - Year-over-year growth 2024-2029 (%)
- Data Table on Europe - Year-over-year growth 2024-2029 (%)
- Chart on Asia - Market size and forecast 2024-2029 ($ million)
- Data Table on Asia - Market size and forecast 2024-2029 ($ million)
- Chart on Asia - Year-over-year growth 2024-2029 (%)
- Data Table on Asia - Year-over-year growth 2024-2029 (%)
- Chart on Rest of World (ROW) - Market size and forecast 2024-2029 ($ million)
- Data Table on Rest of World (ROW) - Market size and forecast 2024-2029 ($ million)
- Chart on Rest of World (ROW) - Year-over-year growth 2024-2029 (%)
- Data Table on Rest of World (ROW) - Year-over-year growth 2024-2029 (%)
- Chart on US - Market size and forecast 2024-2029 ($ million)
- Data Table on US - Market size and forecast 2024-2029 ($ million)
- Chart on US - Year-over-year growth 2024-2029 (%)
- Data Table on US - Year-over-year growth 2024-2029 (%)
- Chart on Greece - Market size and forecast 2024-2029 ($ million)
- Data Table on Greece - Market size and forecast 2024-2029 ($ million)
- Chart on Greece - Year-over-year growth 2024-2029 (%)
- Data Table on Greece - Year-over-year growth 2024-2029 (%)
- Chart on Canada - Market size and forecast 2024-2029 ($ million)
- Data Table on Canada - Market size and forecast 2024-2029 ($ million)
- Chart on Canada - Year-over-year growth 2024-2029 (%)
- Data Table on Canada - Year-over-year growth 2024-2029 (%)
- Chart on China - Market size and forecast 2024-2029 ($ million)
- Data Table on China - Market size and forecast 2024-2029 ($ million)
- Chart on China - Year-over-year growth 2024-2029 (%)
- Data Table on China - Year-over-year growth 2024-2029 (%)
- Chart on Germany - Market size and forecast 2024-2029 ($ million)
- Data Table on Germany - Market size and forecast 2024-2029 ($ million)
- Chart on Germany - Year-over-year growth 2024-2029 (%)
- Data Table on Germany - Year-over-year growth 2024-2029 (%)
- Chart on India - Market size and forecast 2024-2029 ($ million)
- Data Table on India - Market size and forecast 2024-2029 ($ million)
- Chart on India - Year-over-year growth 2024-2029 (%)
- Data Table on India - Year-over-year growth 2024-2029 (%)
- Chart on Mexico - Market size and forecast 2024-2029 ($ million)
- Data Table on Mexico - Market size and forecast 2024-2029 ($ million)
- Chart on Mexico - Year-over-year growth 2024-2029 (%)
- Data Table on Mexico - Year-over-year growth 2024-2029 (%)
- Chart on France - Market size and forecast 2024-2029 ($ million)
- Data Table on France - Market size and forecast 2024-2029 ($ million)
- Chart on France - Year-over-year growth 2024-2029 (%)
- Data Table on France - Year-over-year growth 2024-2029 (%)
- Chart on Italy - Market size and forecast 2024-2029 ($ million)
- Data Table on Italy - Market size and forecast 2024-2029 ($ million)
- Chart on Italy - Year-over-year growth 2024-2029 (%)
- Data Table on Italy - Year-over-year growth 2024-2029 (%)
- Chart on Japan - Market size and forecast 2024-2029 ($ million)
- Data Table on Japan - Market size and forecast 2024-2029 ($ million)
- Chart on Japan - Year-over-year growth 2024-2029 (%)
- Data Table on Japan - Year-over-year growth 2024-2029 (%)
- Market opportunity By Geographical Landscape ($ million)
- Data Tables on Market opportunity By Geographical Landscape ($ million)
13 Drivers, Challenges, and Opportunity/Restraints
13.1 Market drivers
13.2 Market challenges
13.3 Impact of drivers and challenges
13.2 Market challenges
13.3 Impact of drivers and challenges
- Impact of drivers and challenges in 2024 and 2029
14 Competitive Landscape
14.1 Overview
14.2 Competitive Landscape
14.2 Competitive Landscape
- Overview on criticality of inputs and factors of differentiation
- Overview on factors of disruption
- Impact of key risks on business
15 Competitive Analysis
15.1 Companies profiled
- Companies covered
- Company ranking index
- Matrix on companies position and classification
- AbbVie Inc. - Overview
- AbbVie Inc. - Product / Service
- AbbVie Inc. - Key news
- AbbVie Inc. - Key offerings
- SWOT
- Alkermes Public Ltd. Co. - Overview
- Alkermes Public Ltd. Co. - Product / Service
- Alkermes Public Ltd. Co. - Key offerings
- SWOT
- Bausch Health Companies Inc. - Overview
- Bausch Health Companies Inc. - Business segments
- Bausch Health Companies Inc. - Key news
- Bausch Health Companies Inc. - Key offerings
- Bausch Health Companies Inc. - Segment focus
- SWOT
- Eli Lilly and Co. - Overview
- Eli Lilly and Co. - Product / Service
- Eli Lilly and Co. - Key offerings
- SWOT
- F. Hoffmann La Roche Ltd. - Overview
- F. Hoffmann La Roche Ltd. - Business segments
- F. Hoffmann La Roche Ltd. - Key news
- F. Hoffmann La Roche Ltd. - Key offerings
- F. Hoffmann La Roche Ltd. - Segment focus
- SWOT
- H Lundbeck AS - Overview
- H Lundbeck AS - Product / Service
- H Lundbeck AS - Key offerings
- SWOT
- Johnson and Johnson Services Inc. - Overview
- Johnson and Johnson Services Inc. - Business segments
- Johnson and Johnson Services Inc. - Key news
- Johnson and Johnson Services Inc. - Key offerings
- Johnson and Johnson Services Inc. - Segment focus
- SWOT
- Lupin Ltd. - Overview
- Lupin Ltd. - Business segments
- Lupin Ltd. - Key news
- Lupin Ltd. - Key offerings
- Lupin Ltd. - Segment focus
- SWOT
- Luye Pharma Group Ltd. - Overview
- Luye Pharma Group Ltd. - Business segments
- Luye Pharma Group Ltd. - Key offerings
- Luye Pharma Group Ltd. - Segment focus
- SWOT
- MagVenture AS - Overview
- MagVenture AS - Product / Service
- MagVenture AS - Key offerings
- SWOT
- Otsuka Holdings Co. Ltd. - Overview
- Otsuka Holdings Co. Ltd. - Business segments
- Otsuka Holdings Co. Ltd. - Key news
- Otsuka Holdings Co. Ltd. - Key offerings
- Otsuka Holdings Co. Ltd. - Segment focus
- SWOT
- Pfizer Inc. - Overview
- Pfizer Inc. - Product / Service
- Pfizer Inc. - Key news
- Pfizer Inc. - Key offerings
- SWOT
- Takeda Pharmaceutical Co. Ltd. - Overview
- Takeda Pharmaceutical Co. Ltd. - Product / Service
- Takeda Pharmaceutical Co. Ltd. - Key news
- Takeda Pharmaceutical Co. Ltd. - Key offerings
- SWOT
- Teva Pharmaceutical Industries Ltd. - Overview
- Teva Pharmaceutical Industries Ltd. - Business segments
- Teva Pharmaceutical Industries Ltd. - Key news
- Teva Pharmaceutical Industries Ltd. - Key offerings
- Teva Pharmaceutical Industries Ltd. - Segment focus
- SWOT
- Viatris Inc. - Overview
- Viatris Inc. - Business segments
- Viatris Inc. - Key news
- Viatris Inc. - Key offerings
- Viatris Inc. - Segment focus
- SWOT
16 Appendix
16.1 Scope of the report
16.2 Inclusions and exclusions checklist
16.2 Inclusions and exclusions checklist
- Inclusions checklist
- Exclusions checklist
- Currency conversion rates for US$
- Research methodology
- Information sources
- Data validation
- Validation techniques employed for market sizing
- Data synthesis
- 360 degree market analysis
- List of abbreviations
List of Exhibits
Exhibits 1: Executive Summary - Chart on Market Overview
Exhibits 2: Executive Summary - Data Table on Market Overview
Exhibits 3: Executive Summary - Chart on Global Market Characteristics
Exhibits 4: Executive Summary - Chart on Market By Geographical Landscape
Exhibits 5: Executive Summary - Chart on Market Segmentation by Disease Type
Exhibits 6: Executive Summary - Chart on Market Segmentation by Distribution Channel
Exhibits 7: Executive Summary - Chart on Market Segmentation by Route of Administration
Exhibits 8: Executive Summary - Chart on Incremental Growth
Exhibits 9: Executive Summary - Data Table on Incremental Growth
Exhibits 10: Executive Summary - Chart on Company Market Positioning
Exhibits 11: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Exhibits 12: Overview on criticality of inputs and factors of differentiation
Exhibits 13: Overview on factors of disruption
Exhibits 14: Impact of drivers and challenges in 2024 and 2029
Exhibits 15: Parent Market
Exhibits 16: Data Table on - Parent Market
Exhibits 17: Market characteristics analysis
Exhibits 18: Value chain analysis
Exhibits 19: Offerings of companies included in the market definition
Exhibits 20: Market segments
Exhibits 21: Chart on Global - Market size and forecast 2024-2029 ($ million)
Exhibits 22: Data Table on Global - Market size and forecast 2024-2029 ($ million)
Exhibits 23: Chart on Global Market: Year-over-year growth 2024-2029 (%)
Exhibits 24: Data Table on Global Market: Year-over-year growth 2024-2029 (%)
Exhibits 25: Historic Market Size - Data Table on Global Antidepressants Drugs Market 2019 - 2023 ($ million)
Exhibits 26: Historic Market Size - Disease Type Segment 2019 - 2023 ($ million)
Exhibits 27: Historic Market Size - Distribution Channel Segment 2019 - 2023 ($ million)
Exhibits 28: Historic Market Size - Route of Administration Segment 2019 - 2023 ($ million)
Exhibits 29: Historic Market Size - Geography Segment 2019 - 2023 ($ million)
Exhibits 30: Historic Market Size - Country Segment 2019 - 2023 ($ million)
Exhibits 31: Five forces analysis - Comparison between 2024 and 2029
Exhibits 32: Bargaining power of buyers - Impact of key factors 2024 and 2029
Exhibits 33: Bargaining power of suppliers - Impact of key factors in 2024 and 2029
Exhibits 34: Threat of new entrants - Impact of key factors in 2024 and 2029
Exhibits 35: Threat of substitutes - Impact of key factors in 2024 and 2029
Exhibits 36: Threat of rivalry - Impact of key factors in 2024 and 2029
Exhibits 37: Chart on Market condition - Five forces 2024 and 2029
Exhibits 38: Chart on Disease Type - Market share 2024-2029 (%)
Exhibits 39: Data Table on Disease Type - Market share 2024-2029 (%)
Exhibits 40: Chart on Comparison by Disease Type
Exhibits 41: Data Table on Comparison by Disease Type
Exhibits 42: Chart on Major depressive disorder - Market size and forecast 2024-2029 ($ million)
Exhibits 43: Data Table on Major depressive disorder - Market size and forecast 2024-2029 ($ million)
Exhibits 44: Chart on Major depressive disorder - Year-over-year growth 2024-2029 (%)
Exhibits 45: Data Table on Major depressive disorder - Year-over-year growth 2024-2029 (%)
Exhibits 46: Chart on Obsessive compulsive disorder - Market size and forecast 2024-2029 ($ million)
Exhibits 47: Data Table on Obsessive compulsive disorder - Market size and forecast 2024-2029 ($ million)
Exhibits 48: Chart on Obsessive compulsive disorder - Year-over-year growth 2024-2029 (%)
Exhibits 49: Data Table on Obsessive compulsive disorder - Year-over-year growth 2024-2029 (%)
Exhibits 50: Chart on Others - Market size and forecast 2024-2029 ($ million)
Exhibits 51: Data Table on Others - Market size and forecast 2024-2029 ($ million)
Exhibits 52: Chart on Others - Year-over-year growth 2024-2029 (%)
Exhibits 53: Data Table on Others - Year-over-year growth 2024-2029 (%)
Exhibits 54: Market opportunity by Disease Type ($ million)
Exhibits 55: Data Table on Market opportunity by Disease Type ($ million)
Exhibits 56: Chart on Distribution Channel - Market share 2024-2029 (%)
Exhibits 57: Data Table on Distribution Channel - Market share 2024-2029 (%)
Exhibits 58: Chart on Comparison by Distribution Channel
Exhibits 59: Data Table on Comparison by Distribution Channel
Exhibits 60: Chart on Retail pharmacies - Market size and forecast 2024-2029 ($ million)
Exhibits 61: Data Table on Retail pharmacies - Market size and forecast 2024-2029 ($ million)
Exhibits 62: Chart on Retail pharmacies - Year-over-year growth 2024-2029 (%)
Exhibits 63: Data Table on Retail pharmacies - Year-over-year growth 2024-2029 (%)
Exhibits 64: Chart on Hospital pharmacies - Market size and forecast 2024-2029 ($ million)
Exhibits 65: Data Table on Hospital pharmacies - Market size and forecast 2024-2029 ($ million)
Exhibits 66: Chart on Hospital pharmacies - Year-over-year growth 2024-2029 (%)
Exhibits 67: Data Table on Hospital pharmacies - Year-over-year growth 2024-2029 (%)
Exhibits 68: Chart on Online pharmacies - Market size and forecast 2024-2029 ($ million)
Exhibits 69: Data Table on Online pharmacies - Market size and forecast 2024-2029 ($ million)
Exhibits 70: Chart on Online pharmacies - Year-over-year growth 2024-2029 (%)
Exhibits 71: Data Table on Online pharmacies - Year-over-year growth 2024-2029 (%)
Exhibits 72: Market opportunity by Distribution Channel ($ million)
Exhibits 73: Data Table on Market opportunity by Distribution Channel ($ million)
Exhibits 74: Chart on Route of Administration - Market share 2024-2029 (%)
Exhibits 75: Data Table on Route of Administration - Market share 2024-2029 (%)
Exhibits 76: Chart on Comparison by Route of Administration
Exhibits 77: Data Table on Comparison by Route of Administration
Exhibits 78: Chart on Oral - Market size and forecast 2024-2029 ($ million)
Exhibits 79: Data Table on Oral - Market size and forecast 2024-2029 ($ million)
Exhibits 80: Chart on Oral - Year-over-year growth 2024-2029 (%)
Exhibits 81: Data Table on Oral - Year-over-year growth 2024-2029 (%)
Exhibits 82: Chart on Intravenous (IV) - Market size and forecast 2024-2029 ($ million)
Exhibits 83: Data Table on Intravenous (IV) - Market size and forecast 2024-2029 ($ million)
Exhibits 84: Chart on Intravenous (IV) - Year-over-year growth 2024-2029 (%)
Exhibits 85: Data Table on Intravenous (IV) - Year-over-year growth 2024-2029 (%)
Exhibits 86: Chart on Nasal - Market size and forecast 2024-2029 ($ million)
Exhibits 87: Data Table on Nasal - Market size and forecast 2024-2029 ($ million)
Exhibits 88: Chart on Nasal - Year-over-year growth 2024-2029 (%)
Exhibits 89: Data Table on Nasal - Year-over-year growth 2024-2029 (%)
Exhibits 90: Chart on Subcutaneous - Market size and forecast 2024-2029 ($ million)
Exhibits 91: Data Table on Subcutaneous - Market size and forecast 2024-2029 ($ million)
Exhibits 92: Chart on Subcutaneous - Year-over-year growth 2024-2029 (%)
Exhibits 93: Data Table on Subcutaneous - Year-over-year growth 2024-2029 (%)
Exhibits 94: Chart on Others - Market size and forecast 2024-2029 ($ million)
Exhibits 95: Data Table on Others - Market size and forecast 2024-2029 ($ million)
Exhibits 96: Chart on Others - Year-over-year growth 2024-2029 (%)
Exhibits 97: Data Table on Others - Year-over-year growth 2024-2029 (%)
Exhibits 98: Market opportunity by Route of Administration ($ million)
Exhibits 99: Data Table on Market opportunity by Route of Administration ($ million)
Exhibits 100: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Exhibits 101: Chart on Market share By Geographical Landscape 2024-2029 (%)
Exhibits 102: Data Table on Market share By Geographical Landscape 2024-2029 (%)
Exhibits 103: Chart on Geographic comparison
Exhibits 104: Data Table on Geographic comparison
Exhibits 105: Chart on North America - Market size and forecast 2024-2029 ($ million)
Exhibits 106: Data Table on North America - Market size and forecast 2024-2029 ($ million)
Exhibits 107: Chart on North America - Year-over-year growth 2024-2029 (%)
Exhibits 108: Data Table on North America - Year-over-year growth 2024-2029 (%)
Exhibits 109: Chart on Europe - Market size and forecast 2024-2029 ($ million)
Exhibits 110: Data Table on Europe - Market size and forecast 2024-2029 ($ million)
Exhibits 111: Chart on Europe - Year-over-year growth 2024-2029 (%)
Exhibits 112: Data Table on Europe - Year-over-year growth 2024-2029 (%)
Exhibits 113: Chart on Asia - Market size and forecast 2024-2029 ($ million)
Exhibits 114: Data Table on Asia - Market size and forecast 2024-2029 ($ million)
Exhibits 115: Chart on Asia - Year-over-year growth 2024-2029 (%)
Exhibits 116: Data Table on Asia - Year-over-year growth 2024-2029 (%)
Exhibits 117: Chart on Rest of World (ROW) - Market size and forecast 2024-2029 ($ million)
Exhibits 118: Data Table on Rest of World (ROW) - Market size and forecast 2024-2029 ($ million)
Exhibits 119: Chart on Rest of World (ROW) - Year-over-year growth 2024-2029 (%)
Exhibits 120: Data Table on Rest of World (ROW) - Year-over-year growth 2024-2029 (%)
Exhibits 121: Chart on US - Market size and forecast 2024-2029 ($ million)
Exhibits 122: Data Table on US - Market size and forecast 2024-2029 ($ million)
Exhibits 123: Chart on US - Year-over-year growth 2024-2029 (%)
Exhibits 124: Data Table on US - Year-over-year growth 2024-2029 (%)
Exhibits 125: Chart on Greece - Market size and forecast 2024-2029 ($ million)
Exhibits 126: Data Table on Greece - Market size and forecast 2024-2029 ($ million)
Exhibits 127: Chart on Greece - Year-over-year growth 2024-2029 (%)
Exhibits 128: Data Table on Greece - Year-over-year growth 2024-2029 (%)
Exhibits 129: Chart on Canada - Market size and forecast 2024-2029 ($ million)
Exhibits 130: Data Table on Canada - Market size and forecast 2024-2029 ($ million)
Exhibits 131: Chart on Canada - Year-over-year growth 2024-2029 (%)
Exhibits 132: Data Table on Canada - Year-over-year growth 2024-2029 (%)
Exhibits 133: Chart on China - Market size and forecast 2024-2029 ($ million)
Exhibits 134: Data Table on China - Market size and forecast 2024-2029 ($ million)
Exhibits 135: Chart on China - Year-over-year growth 2024-2029 (%)
Exhibits 136: Data Table on China - Year-over-year growth 2024-2029 (%)
Exhibits 137: Chart on Germany - Market size and forecast 2024-2029 ($ million)
Exhibits 138: Data Table on Germany - Market size and forecast 2024-2029 ($ million)
Exhibits 139: Chart on Germany - Year-over-year growth 2024-2029 (%)
Exhibits 140: Data Table on Germany - Year-over-year growth 2024-2029 (%)
Exhibits 141: Chart on India - Market size and forecast 2024-2029 ($ million)
Exhibits 142: Data Table on India - Market size and forecast 2024-2029 ($ million)
Exhibits 143: Chart on India - Year-over-year growth 2024-2029 (%)
Exhibits 144: Data Table on India - Year-over-year growth 2024-2029 (%)
Exhibits 145: Chart on Mexico - Market size and forecast 2024-2029 ($ million)
Exhibits 146: Data Table on Mexico - Market size and forecast 2024-2029 ($ million)
Exhibits 147: Chart on Mexico - Year-over-year growth 2024-2029 (%)
Exhibits 148: Data Table on Mexico - Year-over-year growth 2024-2029 (%)
Exhibits 149: Chart on France - Market size and forecast 2024-2029 ($ million)
Exhibits 150: Data Table on France - Market size and forecast 2024-2029 ($ million)
Exhibits 151: Chart on France - Year-over-year growth 2024-2029 (%)
Exhibits 152: Data Table on France - Year-over-year growth 2024-2029 (%)
Exhibits 153: Chart on Italy - Market size and forecast 2024-2029 ($ million)
Exhibits 154: Data Table on Italy - Market size and forecast 2024-2029 ($ million)
Exhibits 155: Chart on Italy - Year-over-year growth 2024-2029 (%)
Exhibits 156: Data Table on Italy - Year-over-year growth 2024-2029 (%)
Exhibits 157: Chart on Japan - Market size and forecast 2024-2029 ($ million)
Exhibits 158: Data Table on Japan - Market size and forecast 2024-2029 ($ million)
Exhibits 159: Chart on Japan - Year-over-year growth 2024-2029 (%)
Exhibits 160: Data Table on Japan - Year-over-year growth 2024-2029 (%)
Exhibits 161: Market opportunity By Geographical Landscape ($ million)
Exhibits 162: Data Tables on Market opportunity By Geographical Landscape ($ million)
Exhibits 163: Impact of drivers and challenges in 2024 and 2029
Exhibits 164: Overview on criticality of inputs and factors of differentiation
Exhibits 165: Overview on factors of disruption
Exhibits 166: Impact of key risks on business
Exhibits 167: Companies covered
Exhibits 168: Company ranking index
Exhibits 169: Matrix on companies position and classification
Exhibits 170: AbbVie Inc. - Overview
Exhibits 171: AbbVie Inc. - Product / Service
Exhibits 172: AbbVie Inc. - Key news
Exhibits 173: AbbVie Inc. - Key offerings
Exhibits 174: SWOT
Exhibits 175: Alkermes Public Ltd. Co. - Overview
Exhibits 176: Alkermes Public Ltd. Co. - Product / Service
Exhibits 177: Alkermes Public Ltd. Co. - Key offerings
Exhibits 178: SWOT
Exhibits 179: Bausch Health Companies Inc. - Overview
Exhibits 180: Bausch Health Companies Inc. - Business segments
Exhibits 181: Bausch Health Companies Inc. - Key news
Exhibits 182: Bausch Health Companies Inc. - Key offerings
Exhibits 183: Bausch Health Companies Inc. - Segment focus
Exhibits 184: SWOT
Exhibits 185: Eli Lilly and Co. - Overview
Exhibits 186: Eli Lilly and Co. - Product / Service
Exhibits 187: Eli Lilly and Co. - Key offerings
Exhibits 188: SWOT
Exhibits 189: F. Hoffmann La Roche Ltd. - Overview
Exhibits 190: F. Hoffmann La Roche Ltd. - Business segments
Exhibits 191: F. Hoffmann La Roche Ltd. - Key news
Exhibits 192: F. Hoffmann La Roche Ltd. - Key offerings
Exhibits 193: F. Hoffmann La Roche Ltd. - Segment focus
Exhibits 194: SWOT
Exhibits 195: H Lundbeck AS - Overview
Exhibits 196: H Lundbeck AS - Product / Service
Exhibits 197: H Lundbeck AS - Key offerings
Exhibits 198: SWOT
Exhibits 199: Johnson and Johnson Services Inc. - Overview
Exhibits 200: Johnson and Johnson Services Inc. - Business segments
Exhibits 201: Johnson and Johnson Services Inc. - Key news
Exhibits 202: Johnson and Johnson Services Inc. - Key offerings
Exhibits 203: Johnson and Johnson Services Inc. - Segment focus
Exhibits 204: SWOT
Exhibits 205: Lupin Ltd. - Overview
Exhibits 206: Lupin Ltd. - Business segments
Exhibits 207: Lupin Ltd. - Key news
Exhibits 208: Lupin Ltd. - Key offerings
Exhibits 209: Lupin Ltd. - Segment focus
Exhibits 210: SWOT
Exhibits 211: Luye Pharma Group Ltd. - Overview
Exhibits 212: Luye Pharma Group Ltd. - Business segments
Exhibits 213: Luye Pharma Group Ltd. - Key offerings
Exhibits 214: Luye Pharma Group Ltd. - Segment focus
Exhibits 215: SWOT
Exhibits 216: MagVenture AS - Overview
Exhibits 217: MagVenture AS - Product / Service
Exhibits 218: MagVenture AS - Key offerings
Exhibits 219: SWOT
Exhibits 220: Otsuka Holdings Co. Ltd. - Overview
Exhibits 221: Otsuka Holdings Co. Ltd. - Business segments
Exhibits 222: Otsuka Holdings Co. Ltd. - Key news
Exhibits 223: Otsuka Holdings Co. Ltd. - Key offerings
Exhibits 224: Otsuka Holdings Co. Ltd. - Segment focus
Exhibits 225: SWOT
Exhibits 226: Pfizer Inc. - Overview
Exhibits 227: Pfizer Inc. - Product / Service
Exhibits 228: Pfizer Inc. - Key news
Exhibits 229: Pfizer Inc. - Key offerings
Exhibits 230: SWOT
Exhibits 231: Takeda Pharmaceutical Co. Ltd. - Overview
Exhibits 232: Takeda Pharmaceutical Co. Ltd. - Product / Service
Exhibits 233: Takeda Pharmaceutical Co. Ltd. - Key news
Exhibits 234: Takeda Pharmaceutical Co. Ltd. - Key offerings
Exhibits 235: SWOT
Exhibits 236: Teva Pharmaceutical Industries Ltd. - Overview
Exhibits 237: Teva Pharmaceutical Industries Ltd. - Business segments
Exhibits 238: Teva Pharmaceutical Industries Ltd. - Key news
Exhibits 239: Teva Pharmaceutical Industries Ltd. - Key offerings
Exhibits 240: Teva Pharmaceutical Industries Ltd. - Segment focus
Exhibits 241: SWOT
Exhibits 242: Viatris Inc. - Overview
Exhibits 243: Viatris Inc. - Business segments
Exhibits 244: Viatris Inc. - Key news
Exhibits 245: Viatris Inc. - Key offerings
Exhibits 246: Viatris Inc. - Segment focus
Exhibits 247: SWOT
Exhibits 248: Inclusions checklist
Exhibits 249: Exclusions checklist
Exhibits 250: Currency conversion rates for US$
Exhibits 251: Research methodology
Exhibits 252: Information sources
Exhibits 253: Data validation
Exhibits 254: Validation techniques employed for market sizing
Exhibits 255: Data synthesis
Exhibits 256: 360 degree market analysis
Exhibits 257: List of abbreviations
Exhibits 2: Executive Summary - Data Table on Market Overview
Exhibits 3: Executive Summary - Chart on Global Market Characteristics
Exhibits 4: Executive Summary - Chart on Market By Geographical Landscape
Exhibits 5: Executive Summary - Chart on Market Segmentation by Disease Type
Exhibits 6: Executive Summary - Chart on Market Segmentation by Distribution Channel
Exhibits 7: Executive Summary - Chart on Market Segmentation by Route of Administration
Exhibits 8: Executive Summary - Chart on Incremental Growth
Exhibits 9: Executive Summary - Data Table on Incremental Growth
Exhibits 10: Executive Summary - Chart on Company Market Positioning
Exhibits 11: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Exhibits 12: Overview on criticality of inputs and factors of differentiation
Exhibits 13: Overview on factors of disruption
Exhibits 14: Impact of drivers and challenges in 2024 and 2029
Exhibits 15: Parent Market
Exhibits 16: Data Table on - Parent Market
Exhibits 17: Market characteristics analysis
Exhibits 18: Value chain analysis
Exhibits 19: Offerings of companies included in the market definition
Exhibits 20: Market segments
Exhibits 21: Chart on Global - Market size and forecast 2024-2029 ($ million)
Exhibits 22: Data Table on Global - Market size and forecast 2024-2029 ($ million)
Exhibits 23: Chart on Global Market: Year-over-year growth 2024-2029 (%)
Exhibits 24: Data Table on Global Market: Year-over-year growth 2024-2029 (%)
Exhibits 25: Historic Market Size - Data Table on Global Antidepressants Drugs Market 2019 - 2023 ($ million)
Exhibits 26: Historic Market Size - Disease Type Segment 2019 - 2023 ($ million)
Exhibits 27: Historic Market Size - Distribution Channel Segment 2019 - 2023 ($ million)
Exhibits 28: Historic Market Size - Route of Administration Segment 2019 - 2023 ($ million)
Exhibits 29: Historic Market Size - Geography Segment 2019 - 2023 ($ million)
Exhibits 30: Historic Market Size - Country Segment 2019 - 2023 ($ million)
Exhibits 31: Five forces analysis - Comparison between 2024 and 2029
Exhibits 32: Bargaining power of buyers - Impact of key factors 2024 and 2029
Exhibits 33: Bargaining power of suppliers - Impact of key factors in 2024 and 2029
Exhibits 34: Threat of new entrants - Impact of key factors in 2024 and 2029
Exhibits 35: Threat of substitutes - Impact of key factors in 2024 and 2029
Exhibits 36: Threat of rivalry - Impact of key factors in 2024 and 2029
Exhibits 37: Chart on Market condition - Five forces 2024 and 2029
Exhibits 38: Chart on Disease Type - Market share 2024-2029 (%)
Exhibits 39: Data Table on Disease Type - Market share 2024-2029 (%)
Exhibits 40: Chart on Comparison by Disease Type
Exhibits 41: Data Table on Comparison by Disease Type
Exhibits 42: Chart on Major depressive disorder - Market size and forecast 2024-2029 ($ million)
Exhibits 43: Data Table on Major depressive disorder - Market size and forecast 2024-2029 ($ million)
Exhibits 44: Chart on Major depressive disorder - Year-over-year growth 2024-2029 (%)
Exhibits 45: Data Table on Major depressive disorder - Year-over-year growth 2024-2029 (%)
Exhibits 46: Chart on Obsessive compulsive disorder - Market size and forecast 2024-2029 ($ million)
Exhibits 47: Data Table on Obsessive compulsive disorder - Market size and forecast 2024-2029 ($ million)
Exhibits 48: Chart on Obsessive compulsive disorder - Year-over-year growth 2024-2029 (%)
Exhibits 49: Data Table on Obsessive compulsive disorder - Year-over-year growth 2024-2029 (%)
Exhibits 50: Chart on Others - Market size and forecast 2024-2029 ($ million)
Exhibits 51: Data Table on Others - Market size and forecast 2024-2029 ($ million)
Exhibits 52: Chart on Others - Year-over-year growth 2024-2029 (%)
Exhibits 53: Data Table on Others - Year-over-year growth 2024-2029 (%)
Exhibits 54: Market opportunity by Disease Type ($ million)
Exhibits 55: Data Table on Market opportunity by Disease Type ($ million)
Exhibits 56: Chart on Distribution Channel - Market share 2024-2029 (%)
Exhibits 57: Data Table on Distribution Channel - Market share 2024-2029 (%)
Exhibits 58: Chart on Comparison by Distribution Channel
Exhibits 59: Data Table on Comparison by Distribution Channel
Exhibits 60: Chart on Retail pharmacies - Market size and forecast 2024-2029 ($ million)
Exhibits 61: Data Table on Retail pharmacies - Market size and forecast 2024-2029 ($ million)
Exhibits 62: Chart on Retail pharmacies - Year-over-year growth 2024-2029 (%)
Exhibits 63: Data Table on Retail pharmacies - Year-over-year growth 2024-2029 (%)
Exhibits 64: Chart on Hospital pharmacies - Market size and forecast 2024-2029 ($ million)
Exhibits 65: Data Table on Hospital pharmacies - Market size and forecast 2024-2029 ($ million)
Exhibits 66: Chart on Hospital pharmacies - Year-over-year growth 2024-2029 (%)
Exhibits 67: Data Table on Hospital pharmacies - Year-over-year growth 2024-2029 (%)
Exhibits 68: Chart on Online pharmacies - Market size and forecast 2024-2029 ($ million)
Exhibits 69: Data Table on Online pharmacies - Market size and forecast 2024-2029 ($ million)
Exhibits 70: Chart on Online pharmacies - Year-over-year growth 2024-2029 (%)
Exhibits 71: Data Table on Online pharmacies - Year-over-year growth 2024-2029 (%)
Exhibits 72: Market opportunity by Distribution Channel ($ million)
Exhibits 73: Data Table on Market opportunity by Distribution Channel ($ million)
Exhibits 74: Chart on Route of Administration - Market share 2024-2029 (%)
Exhibits 75: Data Table on Route of Administration - Market share 2024-2029 (%)
Exhibits 76: Chart on Comparison by Route of Administration
Exhibits 77: Data Table on Comparison by Route of Administration
Exhibits 78: Chart on Oral - Market size and forecast 2024-2029 ($ million)
Exhibits 79: Data Table on Oral - Market size and forecast 2024-2029 ($ million)
Exhibits 80: Chart on Oral - Year-over-year growth 2024-2029 (%)
Exhibits 81: Data Table on Oral - Year-over-year growth 2024-2029 (%)
Exhibits 82: Chart on Intravenous (IV) - Market size and forecast 2024-2029 ($ million)
Exhibits 83: Data Table on Intravenous (IV) - Market size and forecast 2024-2029 ($ million)
Exhibits 84: Chart on Intravenous (IV) - Year-over-year growth 2024-2029 (%)
Exhibits 85: Data Table on Intravenous (IV) - Year-over-year growth 2024-2029 (%)
Exhibits 86: Chart on Nasal - Market size and forecast 2024-2029 ($ million)
Exhibits 87: Data Table on Nasal - Market size and forecast 2024-2029 ($ million)
Exhibits 88: Chart on Nasal - Year-over-year growth 2024-2029 (%)
Exhibits 89: Data Table on Nasal - Year-over-year growth 2024-2029 (%)
Exhibits 90: Chart on Subcutaneous - Market size and forecast 2024-2029 ($ million)
Exhibits 91: Data Table on Subcutaneous - Market size and forecast 2024-2029 ($ million)
Exhibits 92: Chart on Subcutaneous - Year-over-year growth 2024-2029 (%)
Exhibits 93: Data Table on Subcutaneous - Year-over-year growth 2024-2029 (%)
Exhibits 94: Chart on Others - Market size and forecast 2024-2029 ($ million)
Exhibits 95: Data Table on Others - Market size and forecast 2024-2029 ($ million)
Exhibits 96: Chart on Others - Year-over-year growth 2024-2029 (%)
Exhibits 97: Data Table on Others - Year-over-year growth 2024-2029 (%)
Exhibits 98: Market opportunity by Route of Administration ($ million)
Exhibits 99: Data Table on Market opportunity by Route of Administration ($ million)
Exhibits 100: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Exhibits 101: Chart on Market share By Geographical Landscape 2024-2029 (%)
Exhibits 102: Data Table on Market share By Geographical Landscape 2024-2029 (%)
Exhibits 103: Chart on Geographic comparison
Exhibits 104: Data Table on Geographic comparison
Exhibits 105: Chart on North America - Market size and forecast 2024-2029 ($ million)
Exhibits 106: Data Table on North America - Market size and forecast 2024-2029 ($ million)
Exhibits 107: Chart on North America - Year-over-year growth 2024-2029 (%)
Exhibits 108: Data Table on North America - Year-over-year growth 2024-2029 (%)
Exhibits 109: Chart on Europe - Market size and forecast 2024-2029 ($ million)
Exhibits 110: Data Table on Europe - Market size and forecast 2024-2029 ($ million)
Exhibits 111: Chart on Europe - Year-over-year growth 2024-2029 (%)
Exhibits 112: Data Table on Europe - Year-over-year growth 2024-2029 (%)
Exhibits 113: Chart on Asia - Market size and forecast 2024-2029 ($ million)
Exhibits 114: Data Table on Asia - Market size and forecast 2024-2029 ($ million)
Exhibits 115: Chart on Asia - Year-over-year growth 2024-2029 (%)
Exhibits 116: Data Table on Asia - Year-over-year growth 2024-2029 (%)
Exhibits 117: Chart on Rest of World (ROW) - Market size and forecast 2024-2029 ($ million)
Exhibits 118: Data Table on Rest of World (ROW) - Market size and forecast 2024-2029 ($ million)
Exhibits 119: Chart on Rest of World (ROW) - Year-over-year growth 2024-2029 (%)
Exhibits 120: Data Table on Rest of World (ROW) - Year-over-year growth 2024-2029 (%)
Exhibits 121: Chart on US - Market size and forecast 2024-2029 ($ million)
Exhibits 122: Data Table on US - Market size and forecast 2024-2029 ($ million)
Exhibits 123: Chart on US - Year-over-year growth 2024-2029 (%)
Exhibits 124: Data Table on US - Year-over-year growth 2024-2029 (%)
Exhibits 125: Chart on Greece - Market size and forecast 2024-2029 ($ million)
Exhibits 126: Data Table on Greece - Market size and forecast 2024-2029 ($ million)
Exhibits 127: Chart on Greece - Year-over-year growth 2024-2029 (%)
Exhibits 128: Data Table on Greece - Year-over-year growth 2024-2029 (%)
Exhibits 129: Chart on Canada - Market size and forecast 2024-2029 ($ million)
Exhibits 130: Data Table on Canada - Market size and forecast 2024-2029 ($ million)
Exhibits 131: Chart on Canada - Year-over-year growth 2024-2029 (%)
Exhibits 132: Data Table on Canada - Year-over-year growth 2024-2029 (%)
Exhibits 133: Chart on China - Market size and forecast 2024-2029 ($ million)
Exhibits 134: Data Table on China - Market size and forecast 2024-2029 ($ million)
Exhibits 135: Chart on China - Year-over-year growth 2024-2029 (%)
Exhibits 136: Data Table on China - Year-over-year growth 2024-2029 (%)
Exhibits 137: Chart on Germany - Market size and forecast 2024-2029 ($ million)
Exhibits 138: Data Table on Germany - Market size and forecast 2024-2029 ($ million)
Exhibits 139: Chart on Germany - Year-over-year growth 2024-2029 (%)
Exhibits 140: Data Table on Germany - Year-over-year growth 2024-2029 (%)
Exhibits 141: Chart on India - Market size and forecast 2024-2029 ($ million)
Exhibits 142: Data Table on India - Market size and forecast 2024-2029 ($ million)
Exhibits 143: Chart on India - Year-over-year growth 2024-2029 (%)
Exhibits 144: Data Table on India - Year-over-year growth 2024-2029 (%)
Exhibits 145: Chart on Mexico - Market size and forecast 2024-2029 ($ million)
Exhibits 146: Data Table on Mexico - Market size and forecast 2024-2029 ($ million)
Exhibits 147: Chart on Mexico - Year-over-year growth 2024-2029 (%)
Exhibits 148: Data Table on Mexico - Year-over-year growth 2024-2029 (%)
Exhibits 149: Chart on France - Market size and forecast 2024-2029 ($ million)
Exhibits 150: Data Table on France - Market size and forecast 2024-2029 ($ million)
Exhibits 151: Chart on France - Year-over-year growth 2024-2029 (%)
Exhibits 152: Data Table on France - Year-over-year growth 2024-2029 (%)
Exhibits 153: Chart on Italy - Market size and forecast 2024-2029 ($ million)
Exhibits 154: Data Table on Italy - Market size and forecast 2024-2029 ($ million)
Exhibits 155: Chart on Italy - Year-over-year growth 2024-2029 (%)
Exhibits 156: Data Table on Italy - Year-over-year growth 2024-2029 (%)
Exhibits 157: Chart on Japan - Market size and forecast 2024-2029 ($ million)
Exhibits 158: Data Table on Japan - Market size and forecast 2024-2029 ($ million)
Exhibits 159: Chart on Japan - Year-over-year growth 2024-2029 (%)
Exhibits 160: Data Table on Japan - Year-over-year growth 2024-2029 (%)
Exhibits 161: Market opportunity By Geographical Landscape ($ million)
Exhibits 162: Data Tables on Market opportunity By Geographical Landscape ($ million)
Exhibits 163: Impact of drivers and challenges in 2024 and 2029
Exhibits 164: Overview on criticality of inputs and factors of differentiation
Exhibits 165: Overview on factors of disruption
Exhibits 166: Impact of key risks on business
Exhibits 167: Companies covered
Exhibits 168: Company ranking index
Exhibits 169: Matrix on companies position and classification
Exhibits 170: AbbVie Inc. - Overview
Exhibits 171: AbbVie Inc. - Product / Service
Exhibits 172: AbbVie Inc. - Key news
Exhibits 173: AbbVie Inc. - Key offerings
Exhibits 174: SWOT
Exhibits 175: Alkermes Public Ltd. Co. - Overview
Exhibits 176: Alkermes Public Ltd. Co. - Product / Service
Exhibits 177: Alkermes Public Ltd. Co. - Key offerings
Exhibits 178: SWOT
Exhibits 179: Bausch Health Companies Inc. - Overview
Exhibits 180: Bausch Health Companies Inc. - Business segments
Exhibits 181: Bausch Health Companies Inc. - Key news
Exhibits 182: Bausch Health Companies Inc. - Key offerings
Exhibits 183: Bausch Health Companies Inc. - Segment focus
Exhibits 184: SWOT
Exhibits 185: Eli Lilly and Co. - Overview
Exhibits 186: Eli Lilly and Co. - Product / Service
Exhibits 187: Eli Lilly and Co. - Key offerings
Exhibits 188: SWOT
Exhibits 189: F. Hoffmann La Roche Ltd. - Overview
Exhibits 190: F. Hoffmann La Roche Ltd. - Business segments
Exhibits 191: F. Hoffmann La Roche Ltd. - Key news
Exhibits 192: F. Hoffmann La Roche Ltd. - Key offerings
Exhibits 193: F. Hoffmann La Roche Ltd. - Segment focus
Exhibits 194: SWOT
Exhibits 195: H Lundbeck AS - Overview
Exhibits 196: H Lundbeck AS - Product / Service
Exhibits 197: H Lundbeck AS - Key offerings
Exhibits 198: SWOT
Exhibits 199: Johnson and Johnson Services Inc. - Overview
Exhibits 200: Johnson and Johnson Services Inc. - Business segments
Exhibits 201: Johnson and Johnson Services Inc. - Key news
Exhibits 202: Johnson and Johnson Services Inc. - Key offerings
Exhibits 203: Johnson and Johnson Services Inc. - Segment focus
Exhibits 204: SWOT
Exhibits 205: Lupin Ltd. - Overview
Exhibits 206: Lupin Ltd. - Business segments
Exhibits 207: Lupin Ltd. - Key news
Exhibits 208: Lupin Ltd. - Key offerings
Exhibits 209: Lupin Ltd. - Segment focus
Exhibits 210: SWOT
Exhibits 211: Luye Pharma Group Ltd. - Overview
Exhibits 212: Luye Pharma Group Ltd. - Business segments
Exhibits 213: Luye Pharma Group Ltd. - Key offerings
Exhibits 214: Luye Pharma Group Ltd. - Segment focus
Exhibits 215: SWOT
Exhibits 216: MagVenture AS - Overview
Exhibits 217: MagVenture AS - Product / Service
Exhibits 218: MagVenture AS - Key offerings
Exhibits 219: SWOT
Exhibits 220: Otsuka Holdings Co. Ltd. - Overview
Exhibits 221: Otsuka Holdings Co. Ltd. - Business segments
Exhibits 222: Otsuka Holdings Co. Ltd. - Key news
Exhibits 223: Otsuka Holdings Co. Ltd. - Key offerings
Exhibits 224: Otsuka Holdings Co. Ltd. - Segment focus
Exhibits 225: SWOT
Exhibits 226: Pfizer Inc. - Overview
Exhibits 227: Pfizer Inc. - Product / Service
Exhibits 228: Pfizer Inc. - Key news
Exhibits 229: Pfizer Inc. - Key offerings
Exhibits 230: SWOT
Exhibits 231: Takeda Pharmaceutical Co. Ltd. - Overview
Exhibits 232: Takeda Pharmaceutical Co. Ltd. - Product / Service
Exhibits 233: Takeda Pharmaceutical Co. Ltd. - Key news
Exhibits 234: Takeda Pharmaceutical Co. Ltd. - Key offerings
Exhibits 235: SWOT
Exhibits 236: Teva Pharmaceutical Industries Ltd. - Overview
Exhibits 237: Teva Pharmaceutical Industries Ltd. - Business segments
Exhibits 238: Teva Pharmaceutical Industries Ltd. - Key news
Exhibits 239: Teva Pharmaceutical Industries Ltd. - Key offerings
Exhibits 240: Teva Pharmaceutical Industries Ltd. - Segment focus
Exhibits 241: SWOT
Exhibits 242: Viatris Inc. - Overview
Exhibits 243: Viatris Inc. - Business segments
Exhibits 244: Viatris Inc. - Key news
Exhibits 245: Viatris Inc. - Key offerings
Exhibits 246: Viatris Inc. - Segment focus
Exhibits 247: SWOT
Exhibits 248: Inclusions checklist
Exhibits 249: Exclusions checklist
Exhibits 250: Currency conversion rates for US$
Exhibits 251: Research methodology
Exhibits 252: Information sources
Exhibits 253: Data validation
Exhibits 254: Validation techniques employed for market sizing
Exhibits 255: Data synthesis
Exhibits 256: 360 degree market analysis
Exhibits 257: List of abbreviations
Executive Summary
The following companies are recognized as the key players in the global antidepressants drugs market: AbbVie Inc., Alkermes Public Ltd. Co., Bausch Health Companies Inc., Eli Lilly and Co., F. Hoffmann La Roche Ltd., H Lundbeck AS, Johnson and Johnson Services Inc., Lupin Ltd., Luye Pharma Group Ltd., MagVenture AS, Otsuka Holdings Co. Ltd., Pfizer Inc., Takeda Pharmaceutical Co. Ltd., Teva Pharmaceutical Industries Ltd., and Viatris Inc..Commenting on the report, an analyst from the research team said: "The latest trend gaining momentum in the market is development and approval of new drugs."
According to the report, one of the major drivers for this market is the rising prevalence of depression.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors.
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- AbbVie Inc.
- Alkermes Public Ltd. Co.
- Bausch Health Companies Inc.
- Eli Lilly and Co.
- F. Hoffmann La Roche Ltd.
- H Lundbeck AS
- Johnson and Johnson Services Inc.
- Lupin Ltd.
- Luye Pharma Group Ltd.
- MagVenture AS
- Otsuka Holdings Co. Ltd.
- Pfizer Inc.
- Takeda Pharmaceutical Co. Ltd.
- Teva Pharmaceutical Industries Ltd.
- Viatris Inc.
